| (USD) | Mar 2022 | Y/Y change |
|---|---|---|
| Revenue | 270.00K | — |
| Operating expense | — | — |
| Net income | -15.98M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GNCAQ returned +900.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +900.0% |
| 1 year | +900.0% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $155.20 (Apr 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GNCAQ would be worth today ›No. Genocea Biosciences, Inc. has not paid a dividend in the past 12 months.
Genocea Biosciences, Inc. is part of the Healthcare sector.
Genocea Biosciences, Inc. has a market cap of 5.88K USD, based on the latest quote.